Related Experiment Videos
Regulation of Raf-Akt Cross-talk
Karin Moelling1, Karen Schad, Magnus Bosse
1Institute of Medical Virology, University of Zurich, Gloriastrasse 30, 8028 Zurich, Switzerland. moelling@immv.unizh.ch
Abstract:
We have recently shown that the Ras-Raf-MEK-ERK and phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathways can cross-talk in the human breast cancer cell line MCF-7. High Raf activity induces growth arrest and differentiation in these cells, whereas high PI3K/Akt activity correlates with cell survival and proliferation. Here we show that the Raf-Akt cross-talk is regulated in a concentration- and ligand-dependent manner. High doses of insulin-like growth factor I (IGF-I) activate Akt quickly and strongly enough to suppress Raf kinase activity via phosphorylation of Ser-259, whereas low doses of IGF-I do not trigger this cross-talk but are still mitogenic. Phorbol 12-myristate 13-acetate, a differentiation-inducing stimulus, potently activates the Ras-Raf-MEK-ERK pathway but only weakly activates PI3K/Akt and does not trigger the cross-talk. Thus, the herein analyzed parameters such as ligand type, concentration, and time course may contribute to the cellular response of either proliferation or differentiation. This is highly relevant to understanding cellular transformation and may be of use in areas like tissue engineering.
Insights
Cell signaling pathways, Ras-Raf-MEK-ERK and PI3K-Akt, cross-talk is regulated by ligand type and concentration. This impacts cellular response, influencing proliferation or differentiation in breast cancer cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- The Ras-Raf-MEK-ERK and PI3K-Akt signaling pathways are crucial in cell regulation.
- Cross-talk between these pathways influences cell fate decisions like proliferation and differentiation.
- Dysregulation of these pathways is implicated in human breast cancer.
Purpose of the Study:
- To investigate the regulatory mechanisms of Raf-Akt cross-talk.
- To determine how ligand type, concentration, and time course affect pathway activation and cellular response.
- To understand the implications for cellular transformation and potential applications in tissue engineering.
Main Methods:
- Utilized the human breast cancer cell line MCF-7.
- Analyzed signaling pathway activation (Ras-Raf-MEK-ERK and PI3K-Akt) in response to varying doses of insulin-like growth factor I (IGF-I).
- Assessed the impact of phorbol 12-myristate 13-acetate on pathway activation and cross-talk.
Main Results:
- High doses of IGF-I activated PI3K-Akt, suppressing Raf kinase activity via Ser-259 phosphorylation.
- Low doses of IGF-I were mitogenic but did not trigger Raf-Akt cross-talk.
- Phorbol 12-myristate 13-acetate activated Ras-Raf-MEK-ERK but weakly activated PI3K-Akt, without triggering cross-talk.
- Raf activity induces growth arrest and differentiation, while PI3K/Akt activity promotes survival and proliferation.
Conclusions:
- Raf-Akt cross-talk is a concentration- and ligand-dependent process.
- Ligand type, concentration, and time course are critical determinants of cellular response (proliferation vs. differentiation).
- Understanding these signaling dynamics is vital for comprehending cellular transformation and for applications in tissue engineering.